OCX / OncoCyte (OCX) Reports Q4 Loss, Lags Revenue Estimates

OncoCyte Corporation (NASDAQ:OCX ) Q2 2023 Earnings Conference Call August 10, 2023 8:00 AM ET Company Participants Stephanie Prince - PCG Advisory, I more_horizontal

IRVINE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that it will more_horizontal

Fintel reports that Broadwood Partners has filed a 13D/A form with the SEC disclosing ownership of 57.13MM shares of OncoCyte Corp (OCX). more_horizontal

Oncocyte Corp. shares rose 5% in premarket trades after the Irvine, Calif., molecular diagnostics company for the detection of cancer, said it would r more_horizontal

OncoCyte Corporation (NASDAQ:OCX ) Q3 2022 Results Conference Call November 10, 2022 4:30 PM ET Company Participants Caroline Corner - Investor Relati more_horizontal

OncoCyte Corporation (NASDAQ:OCX ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Caroline Corner - Westwicke, Inves more_horizontal

OncoCyte (OCX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). more_horizontal

OncoCyte Corporation (NASDAQ:OCX ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Ronnie Andrews – President and Chie more_horizontal